NEW YORK, Feb. 27, 2017 -- WisdomTree Investments, Inc. (NASDAQ:WETF), an exchange-traded fund ("ETF") and exchange-traded product ("ETP") sponsor and asset manager, today announced that three additional ETFs have recently filed notification with the Financial Services Agency of Japan (FSA).
The three newly notified ETFs offer differentiated foreign fixed income solutions to retail investors in Japan at a time when many Japanese investors are looking to diversify with foreign bonds for additional income and return potential. The newly notified funds include:
- The WisdomTree Negative Duration High Yield Bond Fund[*] (HYND) a high-yield bond strategy designed to provide investors with a means of investing in a rising U.S. interest rate setting while still generating income from high yield corporate bond exposures.
- The WisdomTree Barclays Yield Enhanced U.S. Aggregate Bond Fund[†] (AGGY) which offers investors access to core fixed income by looking within the Bloomberg Barclays U.S. Aggregate Index (Agg) universe to enhance income.
- The WisdomTree Interest Rate Hedged High Yield Bond Fund[‡] (HYZD) which can help investors reduce the interest rate risk of their overall portfolio while supplementing income levels.
Previously Notified Funds
| Ticker | Fund Name |
| DLN | WisdomTree LargeCap Dividend Fund |
| DON | WisdomTree MidCap Dividend Fund |
| DES | WisdomTree SmallCap Dividend Fund |
| DGRW | WisdomTree U.S. Quality Dividend Growth Fund |
| DGRS | WisdomTree U.S. SmallCap Quality Dividend Growth Fund |
| EUDG | WisdomTree Europe Quality Dividend Growth Fund |
| DGS | WisdomTree Emerging Markets SmallCap Dividend Fund |
| DGRE | WisdomTree Emerging Markets Quality Dividend Growth Fund |
| DYLS | WisdomTree Dynamic Long/Short U.S. Equity Fund |
| DYB | WisdomTree Dynamic Bearish U.S. Equity Fund |
| DFJ | WisdomTree Japan SmallCap Dividend Fund |
| DXJF | WisdomTree Japan Hedged Financials Fund |
| DXJH | WisdomTree Japan Hedged Health Care Fund |
| DXJR | WisdomTree Japan Hedged Real Estate Fund |
| DXJC | WisdomTree Japan Hedged Capital Goods Fund |
| DFE | WisdomTree Europe SmallCap Dividend Fund |
| DEW | WisdomTree Global High Dividend Fund |
| GULF | WisdomTree Middle East Dividend Fund |
| DXJS | WisdomTree Japan Hedged SmallCap Equity Fund |
| EPI | WisdomTree India Earnings Fund |
| DXJ | WisdomTree Japan Hedged Equity Fund |
| HEDJ | WisdomTree Europe Hedged Equity Fund |
| DEM | WisdomTree Emerging Markets High Dividend Fund |
| DHS | WisdomTree High Dividend Fund |
| ELD | WisdomTree Emerging Markets Local Debt Fund |
About WisdomTree
WisdomTree Investments, Inc., through its subsidiaries in the U.S., Europe, Japan and Canada (collectively, "WisdomTree"), is an exchange-traded fund ("ETF") and exchange-traded product ("ETP") sponsor and asset manager headquartered in New York. WisdomTree offers products covering equities, fixed income, currencies, commodities and alternative strategies. WisdomTree currently has approximately $43.3 billion in assets under management globally.
WisdomTree® is the marketing name for WisdomTree Investments, Inc. and its subsidiaries worldwide.
* Formerly WisdomTree BofA Merrill Lynch High Yield Bond Negative Duration Fund
† Formerly WisdomTree Barclays U.S. Aggregate Bond Enhanced Yield Fund
‡ Formerly WisdomTree BofA Merrill Lynch High Yield Bond Zero Duration Fund
Contact Information: Media Relations WisdomTree Investments, Inc. Jessica Zaloom / Melissa Chiles +1.917.267.3735 / +1.917.267.3797 [email protected] / [email protected] Investor Relations WisdomTree Investments, Inc. Jason Weyeneth, CFA +1.917.267.3858 [email protected]


Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 



